🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prediction of Pancreatogenic Diabetes After Partial Resection of the Pancreas

Recruitingn/aAges 18 Years - anyAllUniversity Medical Centre Ljubljana
NCT07665710 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The primary aim of the study is to identify clinical, laboratory, imaging, and pathohistological risk factors for the development of pancreatogenic diabetes after partial resection of the pancreas (PRP) and, based on these, to build a predictive model that would enable reliable and accurate identification of patients who will develop pancreatogenic diabetes. A review of the literature shows that there is currently no validated tool available in clinical practice for identifying patients at risk of this type of diabetes after PRP. Etiological differences between type 2 diabetes and pancreatogenic diabetes often lead to late diagnosis, limiting opportunities for timely intervention. The development of a comprehensive predictive model would contribute to a better understanding of the pathophysiology of pancreatogenic diabetes, enable the identification of patients at risk, facilitate tailor

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * age ≥ 18 years * planned partial resection of the pancreas * absence of known diabetes before the procedure * absence of known borderline basal glycemia before the procedure * absence of impaired glucose tolerance before the procedure * signed written informed consent Exclusion Criteria: * known diabetes mellitus before the procedure * known borderline basal glycemia before the procedure * impaired glucose tolerance before the procedure * inability to provide informed consent * withdrawal of consent during the course of the study * total resection of the pancreas * a subsequent decision for conservative treatment (based on clinical characteristics at the time of the surgical procedure)
💊

What it tests

  • Not listed
📍

Where

1 site
University Medical Centre Ljubljana
Ljubljana, Slovenia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy